Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Gelesis Holdings, Inc. GLS
$0.16
На 18:05, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
11630550.00000000
-
week52high
5.67
-
week52low
0.01
-
Revenue
25767000
-
P/E TTM
0
-
Beta
0.99375000
-
EPS
-1.30000000
-
Last Dividend
0.00000000
-
Next Earnings Date
10 мая 2023 г. в 10:59
Описание компании
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipeline with potential therapies for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis, type 2 diabetes, and GS500 for Functional Constipation. Gelesis Holdings Inc. was incorporated in 2006 and is headquartered in Boston, Massachusetts.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Citigroup | Neutral | 20 сент 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| KUCHERLAPATI RAJU S | A | 190264 | 92000 | 21 ноя 2022 г. |
| KUCHERLAPATI RAJU S | A | 98264 | 8000 | 18 ноя 2022 г. |
| KUCHERLAPATI RAJU S | A | 90264 | 24625 | 15 июн 2022 г. |
| Sannino Alessandro | A | 333392 | 333392 | 08 июн 2022 г. |
| Sannino Alessandro | A | 0 | 333392 | 08 июн 2022 г. |
| Chiquette Elaine | A | 80500 | 80500 | 08 июн 2022 г. |
| Chiquette Elaine | A | 263079 | 80500 | 08 июн 2022 г. |
| Wildman Jane | A | 50182 | 50182 | 06 мая 2022 г. |
| Perks Dominic | A | 49270 | 49270 | 06 мая 2022 г. |
| Pass David A. | A | 431456 | 431456 | 06 мая 2022 г. |
Новостная лента
Gelesis Holdings, Inc. (GLS) Q3 2022 Earnings Call Transcript
Seeking Alpha
14 ноя 2022 г. в 12:20
Gelesis Holdings, Inc. (NYSE:GLS ) Q3 2022 Earnings Conference Call November 14, 2022 8:30 AM ET Company Participants Anna Kate Heller - IR Yishai Zohar - Founder and CEO Elliot Maltz – CFO Conference Call Participants Daniel Grosslight - Citi Operator Hello, and welcome to the Gelesis Third Quarter 2022 Earnings Conference Call. My name is Elliot, and I'll be coordinating your call today.
Dr. Frank Greenway to Present Data from the LIGHT-UP Study with Gelesis' Oral Hydrogel Treatment GS200 at Obesity Week
Business Wire
01 ноя 2022 г. в 17:24
BOSTON--(BUSINESS WIRE)--Gelesis Holdings Inc. (NYSE: GLS) (“Gelesis” or the “Company”) the maker of Plenity for weight management, today announced Dr. Frank Greenway will give an oral presentation at Obesity Week in San Diego, on Wednesday, November 2 at 4:00pm PDT.
Gelesis Holdings, Inc. (GLS) CEO Yishai Zohar on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
15 авг 2022 г. в 11:53
Gelesis Holdings, Inc. (NYSE:GLS ) Q2 2022 Earnings Conference Call August 15, 2022 8:30 AM ET Company Participants Anna Heller - IR Yishai Zohar - Founder & CEO Elliot Maltz - CFO David Pass - COO & CCO Conference Call Participants Operator Hello, everyone. And welcome to the Gelesis' Second Quarter 2022 Earnings Conference Call.
Gelesis Holdings' (GLS) CEO Yishai Zohar on Q1 2022 Results - Earnings Call Transcript
Seeking Alpha
14 мая 2022 г. в 03:18
Gelesis Holdings, Inc. (NYSE:GLS ) Q1 2022 Earnings Conference Call May 1, 2022 4:30 PM ET Company Participants Yishai Zohar – Founder and Chief Executive Officer Elliot Maltz – Chief Financial Officer David Pass – Chief Operating and Commercial Officer Conference Call Participants Ellie Merle – UBS Operator Good afternoon, everyone, and thank you for participating in today's conference call to discuss Gelesis' financial results for the fiscal quarter ended March 31, 2022. Joining us today are Yishai Zohar, Founder and CEO of Gelesis; and Elliot Maltz, CFO of Gelesis.
Gelesis to Report First Quarter 2022 Financial Results on May 12, 2022
Business Wire
09 мая 2022 г. в 06:00
BOSTON--(BUSINESS WIRE)--Gelesis (NYSE: GLS), the maker of Plenity® for weight management, today announced that the Company will report financial results for the First Quarter ended March 31, 2022, on May 12, 2022 following the market close. Gelesis management will host a live conference call and webcast at 4:30 p.m. ET on the same day to discuss the results. Conference Call Details Date: Thursday, May 12, 2022 Time: 4:30 p.m. Eastern Time Toll-free dial-in number: (844) 200-6205 International